Gap Junction Β‑2 Expression Is Negatively Associated With the Estrogen Receptor Status in Breast Cancer Tissues and Is a Regulator of Breast Tumorigenesis

Oncology Reports - Greece
doi 10.3892/or.2018.6764
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Estrogen Receptor Signaling Is Reprogrammed During Breast Tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

MicroRNA-221/222 Negatively Regulates Estrogen Receptor Α and Is Associated With Tamoxifen Resistance in Breast Cancer.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Neuropilin-1 Expression Is Associated With Lymph Node Metastasis in Breast Cancer Tissues

Cancer Management and Research
Oncology
2018English

Is microRNA-31 a Key Regulator of Breast Tumorigenesis?

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Estrogen-Related Receptor Expression and Function Is Associated With the Transcriptional Coregulator AIB1 in Breast Carcinoma

Cancer Research
Cancer ResearchOncology
2009English

‘Stanniocalcin 2 Expression Is Associated With a Favourable Outcome in Male Breast Cancer’

Journal of Pathology: Clinical Research
Forensic MedicinePathology
2019English

Protein Tyrosine Phosphatase 4A2 Expression Predicts Overall and Disease-Free Survival of Human Breast Cancer and Is Associated With Estrogen and Progestin Receptor Status

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2013English

The SWI/SNF Chromatin Remodeling Subunit BAF57 Is a Critical Regulator of Estrogen Receptor Function in Breast Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Toll-Like Receptor 9 Expression in Breast and Ovarian Cancer Is Associated With Poorly Differentiated Tumors

Cancer Science
Cancer ResearchMedicineOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy